What is the IBCWG ?
The International Burkholderia cepacia Working Group (IBCWG) was established in Spring 1996 with support from the Cystic Fibrosis Foundation (US). The IBCWG is open to clinicians and scientists interested in advancing knowledge of B. cepacia infection/colonization in persons with cystic fibrosis through the collegial exchange of information and promotion of coordinated approaches to research.
The initial meeting, hosted by the Cystic Fibrosis Foundation (CFF) at their headquarters in Bethesda, Maryland on June 14, 1996, was attended by 14 individuals with expertise in clinical microbiology, infectious diseases, pulmonary medicine, medical microbiology and bacterial taxonomy. Since then the IBCWG has expanded to include nearly 50 individuals from nine countries in North America, Europe, and Australia.
With financial support from Zeneca Pharma (Canada) and the national cystic fibrosis charitable organizations (including Cystic Fibrosis Foundation (US), Canadian Cystic Fibrosis Foundation, CF Trust (UK), and Belgian Trust), the IBCWG has met twice yearly. A brief meeting is held each Fall in conjunction with the annual North American Cystic Fibrosis Conference and a more comprehensive meeting occurs in the Spring.
During the Spring Meeting in April 2000 in Bethesda, the following Mission Statement was approved.
The IBCWG is an international group whose goals are:
1. To share new clinical and research information in an interdisciplinary fashion among CF clinicians, clinical and research microbiologists, plant pathologists and others with an interest in Burkholderia cepacia.
2. To share bacterial strains, molecular biology techniques and model systems among those in the group.
3. To foster collaborative research interactions among members so that there is a coordinated approach and redundant efforts are avoided.
4. To provide informed opinions in an advisory capacity to parties with an interest in B. cepacia (e.g. the CF community, regulatory agencies, etc).